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Abstract Many studies are uncovering functional roles for long noncoding RNAs (lncRNAs), yet few 
have been tested for in vivo relevance through genetic ablation in animal models. To investigate the 
functional relevance of lncRNAs in various physiological conditions, we have developed a collection 
of 18 lncRNA knockout strains in which the locus is maintained transcriptionally active. Initial 
characterization revealed peri- and postnatal lethal phenotypes in three mutant strains (Fendrr, Peril, 
and Mdgt), the latter two exhibiting incomplete penetrance and growth defects in survivors. We also 
report growth defects for two additional mutant strains (linc–Brn1b and linc–Pint). Further analysis 
revealed defects in lung, gastrointestinal tract, and heart in Fendrr−/− neonates, whereas linc–Brn1b−/− 
mutants displayed distinct abnormalities in the generation of upper layer II–IV neurons in the neocortex. 
This study demonstrates that lncRNAs play critical roles in vivo and provides a framework and impetus 
for future larger-scale functional investigation into the roles of lncRNA molecules.
DOI: 10.7554/eLife.01749.001
Introduction
Mammalian genomes encode thousands of long noncoding RNAs (lncRNAs), which are emerging as 
key regulators of cellular processes (Rinn and Chang, 2012; Mercer and Mattick, 2013). Gain- and 
loss-of-function approaches in cell-based in vitro systems have been useful in uncovering important 
roles for lncRNAs, such as modulating chromatin states, maintaining cellular identity (i.e. pluripotency) 
and regulating cell cycle and translation (Tsai et al., 2010; Guttman et al., 2011; Wang et al., 2011; 
Yoon et al., 2012). Genome-wide association and expression profiling studies in humans have also 
identified correlations between lncRNA mutation, misregulation and disease states (Visel et al., 2010; 
Cabili et al., 2011; Brunner et al., 2012). Yet, direct in vivo, genetic evidence of the functional significance 
of lncRNAs as a class of transcripts remains elusive.
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Functional studies in knockout mouse models have provided compelling evidence for the require-
ment and sufficiency of particular transcripts for organ development and function. However, small and 
large-scale efforts have focused primarily on protein coding genes, leaving long noncoding RNAs 
vastly understudied (Edwards et al., 2011; White et al., 2013). Of the few lncRNA mutant mice gen-
erated to date, most involved previously studied and classic examples of lncRNAs (e.g., Xist, H19, 
Kcn11ot1, Malat1) (Anguera et al., 2011; Gomez et al., 2013; Gordon et al., 2010; Moseley et al., 
2006; Nakagawa et al., 2011; Ripoche et al., 1997; Zhang et al., 2012), leaving the more recent 
large-scale RNA-Seq-derived catalogs of lincRNAs largely unexplored. The progress made in these 
early studies to initiate functional characterization of lncRNAs in vivo now warrants a larger investigation 
of their biological importance to development and disease.
To address this directly, and to begin to explore the roles of lncRNAs in vivo, we have established a 
novel cohort of lncRNA knockout mice. We focused on a subgroup of lncRNAs called long intergenic 
noncoding RNAs (lincRNAs), such that genetic deletion would not overlap known protein coding 
genes or other known gene annotations. We have implemented a generalized and logical lincRNA 
candidate selection process that leverages a collection of cell-based functional assays, RNA-sequencing 
data and computational analyses. This approach led us to identify 18 lincRNAs for targeted deletion 
in mouse. Initial characterization of these new knockout strains demonstrated key functional roles 
in viability, development of the cerebral cortex and other developmental processes. In this study, 
we describe the observed phenotypes for five strains within this collection. Collectively, these data 
provide evidence that lincRNAs play central roles in mammalian development and physiology.
Results
Global characterization of lincRNA knockout candidate selection
To more globally understand the physiological significance of lincRNAs, we combined a step-wise 
lincRNA selection pipeline with a genetic approach to engineer a cohort of lincRNA knockout mouse 
strains for functional analysis. We integrated several computational and experimental data sets to 
select bona fide lincRNA candidates across three lincRNA catalogs (Guttman et al., 2009; UCSC and 
Refseq). First, all transcripts with identifiable Pfam domains or those overlapping known non-lncRNA 
annotations (e.g., annotated protein coding genes, microRNAs, tRNAs and pseudogenes) were excluded. 
Second, we excluded any remaining transcripts with conserved protein coding potential, including 
eLife digest The mammalian genome is comprised of DNA sequences that contain the 
templates for proteins, and other DNA sequences that do not code for proteins. The coding DNA 
sequences are transcribed to make messenger RNA molecules, which are then translated to make 
proteins. Researchers have known for many years that some of the noncoding DNA sequences are 
also transcribed to make other types of RNA molecules, such as transfer and ribosomal RNA. 
However, the true breadth and diversity of the roles played by these other RNA molecules have 
only recently begun to be fully appreciated.
Mammalian genomes contain thousands of noncoding DNA sequences that are transcribed. 
Recent in vitro studies suggest that the resulting long noncoding RNA molecules can act as regulators 
of transcription, translation, and cell cycle. In vitro studies also suggest that these long noncoding 
RNA molecules may play a role in mammalian development and disease. Yet few in vivo studies 
have been performed to support or confirm such hypotheses.
Now Sauvageau et al. have developed several lines of knockout mice to investigate a subset 
of noncoding RNA molecules known as long intergenic noncoding RNAs (lincRNAs). These 
experiments reveal that lincRNAs have a strong influence on the overall viability of mice, and 
also on a number of developmental processes, including the development of lungs and the 
cerebral cortex.
Given that the vast majority of the human genome is transcribed, the mouse models 
developed by Sauvageau et al. represent an important step in determining the physiological 
relevance, on a genetic level, of the noncoding portion of the genome in vivo.
DOI: 10.7554/eLife.01749.002
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the potential to produce small peptides, by performing stringent codon-substitution frequency (CSF) 
analysis (Lin et al., 2011). We previously demonstrated that this algorithm is capable of discriminating 
known functional small peptides down to 11 amino acids (Guttman and Rinn, 2012; Guttman et al., 
2013). Using selective criteria, we restricted candidate lincRNAs to those with CSF scores <−200 
(ranging from −205 to −14,771, Figure 1A). Then, we examined existing ribosome profiling datasets 
to quantitate the ability of these transcripts to engage the ribosome (Figure 1—figure supplement 1). 
None of the tested candidates were shown to have clear translation efficiency or codon bias according 
Figure 1. Properties of the 18 lincRNA candidates and Mendelian inheritance. (A) List of the 18 lincRNA candidates for targeted deletion in mouse and 
overview of criteria used for their selection. (B) Heatmap of log10 FPKM+1 expression levels of the 18 lincRNAs in a panel of adult mouse tissues and cell 
lines via RNA-Seq. (C) Guilt-by-association (GBA) analysis for 17/18 lincRNA candidates. Individual tiles represent significant (p<1.0 × 10−6) gene sets 
from the CP Reactome collection at MSigDB. Tiles are filled based on the Z-score of the Pearson correlation values between a given lincRNA and the 
genes within the gene set across a compendium of RNA-Seq samples. (D) Mendelian inheritance of the 18 lincRNA mutant alleles from the progeny of 
heterozygote intercrosses. Numbers of observed and expected (in parenthesis) wild-type (+/+), heterozygote (+/−) and homozygote (−/−) mice are 
indicated. Mice were genotyped at weaning age. The p value is based on X2 test. † The Spasm gene is located on the X chromosome.
DOI: 10.7554/eLife.01749.003
The following figure supplements are available for figure 1:
Figure supplement 1. Ribosome release score of lncRNAs. 
DOI: 10.7554/eLife.01749.004
Figure supplement 2. lincRNA candidates knockout targeting strategy. 
DOI: 10.7554/eLife.01749.005
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to proposed standards (Guttman et al., 2013). Finally, through genome lift-over of our mouse 
lincRNAs to the human genome (build hg19), we examined mass spectrometry data by Gascoigne 
et al. (2012) to discard transcripts with mapped peptides. We kept transcripts with only two or less 
mass spectrometry tags, consistent with low levels of background ribosome association observed by 
Guttman et al. (2013) (Supplementary file 1B) . Thus, based on an exhaustive analysis of existing 
annotations, standard evolutionary and ribosome profiling metrics, as well as mass spectrometry data, 
these candidates do not appear to contain protein coding potential.
From this stringent list of lincRNAs, we selected 18 candidates by further considering additional crite-
ria: (1) Presence of an observed orthologous human lincRNA with syntenic conservation as determined 
by TransMap (Zhu et al., 2007); (2) Presence of canonical chromatin features of actively transcribed genes 
such as histone H3 lysine 4 trimethylation (H3K4me3) at the promoter and histone H3 lysine 36 trimethyla-
tion throughout the gene body (Guttman et al., 2009, 2010); (3) Local ‘enhancer-like’ signatures based on 
published P300, RNA polymerase II, histone lysine 4 monomethylation (H3K4me1) and histone lysine 
27 acetylation (H3K27ac) chromatin states (Shen et al., 2012). We selected 6/18 candidates lncRNA loci 
that have putative ‘enhancer’ modifications, thus allowing to investigate the newfound roles of lncRNAs in 
‘enhancer’ activity (Ørom et al., 2010; Wang et al., 2011). Collectively, this step-wise selection process 
resulted in 18 high-quality candidate lincRNAs with diverse features, for targeted deletion and phenotypic 
characterization (Figure 1A, Supplementary file 1A for coordinates and nomenclature details).
We first examined the gene-expression patterns of the candidate lincRNAs using RNA-sequencing 
of various adult tissues and cell types. Several lincRNAs presented more restricted patterns of expression, 
suggesting strong tissue specificity, for example Celr in embryonic stem (ES)-derived neural stem cells 
(NSCs), linc–Enc1 in mouse ES cells, Manr and linc–Cox2 in lung, whereas a select few showed more 
ubiquitous expression across tissues (linc–Pint, Spasm, linc–Ppara, Tug1) (Figure 1B). Most of the 
candidate lincRNAs (12/18) were expressed in the adult brain or in ES-derived NSCs (Figure 1B).
Since most candidate lincRNAs in this screen have unknown biological roles, we leveraged our 
RNA-sequencing data using guilt-by-association (GBA) analysis to generate hypotheses on functional 
significance by comparing the expression of each lincRNAs to protein coding genes of known function 
(‘Materials and methods’) (Figure 1C). GBA predicted lincRNA activities across a wide range of pathways 
and biological processes, ranging from regulation of the cell cycle and chromosome organization and 
maintenance, to neuronal differentiation and immune response (Figure 1C). Overall, these analyses 
suggested diverse potential roles for our candidate lincRNAs.
Genetic analysis of lincRNA knockout mice reveals key roles in 
mammalian development
To study the function of the selected 18 lincRNAs in vivo and to resolve, at the cellular level, their 
expression pattern in different organs, we generated knockout mouse strains for each candidate by 
replacing the lincRNA gene with a lacZ reporter cassette (‘Materials and methods’, Figure 1—figure 
supplement 2 for details) (Valenzuela et al., 2003). These new strains, which are the first lincRNA 
knockout models to incorporate a reporter, more than double the number of models available for 
investigation and constitute an important resource that will be used to better understand the functional 
contribution of lincRNAs to mammalian biology.
To assess the requirement for each lincRNA in embryonic development and viability, we examined 
the progeny from heterozygote intercrosses for all 18 strains. Genotyping of weanlings (21 days old) 
revealed normal Mendelian segregation of mutant alleles in 15 of the 18 strains (Figure 1D). For the 
three remaining strains Peril, Mdgt and Fendrr, the progeny of heterozygote intercrosses contained 
much lower numbers of homozygote mutants than expected. Only 13 Peril−/− mice (of an expected 32), 
and 6 Mdgt−/− mice (of an expected 17) were found at weaning age, indicating that deletion of Peril and 
Mdgt leads to reduced viability with >50% and 65% penetrance, respectively (Figure 1D). Closer 
examination of Mdgt pups revealed that homozygous mutants died within 2 weeks after birth. For 
Fendrr, no homozygous mutants were found at weaning age (Figure 1D), indicating that the lethal 
phenotype for this strain is fully penetrant. Thus, 3 out of the 18 (17%) lincRNA knockout strains generated 
have a lethal phenotype, confirming that specific lincRNA genes are required for viability.
Peril−/− mice have reduced viability and die shortly after birth
To determine the onset of Peril−/− mice lethality, we monitored survival at both early and late stages of 
embryonic development. Since normal Mendelian ratios were observed up to E18.5 (Figure 2A), and pups 
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appeared macroscopically normal at birth (Figure 2B), we monitored newborns to see if lethality 
occurred perinatally. We observed that 50% (5/10) of Peril−/− pups died within 2–20 days after birth 
(Figure 2A). A similar percentage (52%, 11/21) of newborn deaths occurred in the progeny of intercrosses 
from surviving Peril−/− mice (Figure 2A, lower panel). These results confirmed the reduced viability of 
Peril mutants (∼50% penetrance) with pups dying early after birth.
Peril is a seven exon transcript derived from a 18.2 Kb genomic locus located ∼110 Kb downstream 
of the pluripotency factor Sox2 (Figure 2C). Using mouse ES cell (mES) cDNA, we were able to 
clone two distinct isoforms (1,831 bp and 631 bp) (Figure 2C). RNAseq expression profiling from 
a panel of mouse tissues and cell lines showed that Peril was highly enriched in mouse ES cells, 
but also expressed at lower levels in adult brain and testes (Figure 2D). The Peril transcript is 
predominantly nuclear as revealed by RNA fluorescence in situ hybridization (FISH) in mouse ES 
cells (Figure 2E). Using the knocked-in lacZ reporter in heterozygote embryos, tight temporal and 
spatial regulation of Peril was found in the brain and spinal cord of E14.5 and E18.5 embryos 
(Figure 2F, Figure 2—figure supplement 1A).
To identify putative pathways affected by deletion of Peril, we performed RNA-sequencing on 
E18.5 brains from Peril−/− and wild-type littermates (n = 2). Analysis of Peril expression levels confirmed 
the deletion of Peril (Figure 2G). Expression of the pluripotency factor Sox2 and its overlapping 
Figure 2. Deletion of Peril leads to reduced viability. (A) Genotyping results from heterozygote intercrosses (Upper panel) at different developmental 
stages (*pups dying within days after birth) and homozygote intercrosses (Lower panel) at birth. The p value is based on X2 test. (B) Newborn (P0) 
Peril−/− mutants and wild-type littermates. (C) Peril genomic locus and targeting scheme. (D) RNA-Seq expression profile for Peril across a panel of 
mouse tissues and cell types. (E) Single-molecule FISH targeting Peril in wild type mouse embryonic stem cells (mES). Nuclei were stained with 
DAPI. (F) Whole mount and coronal section lacZ stainings reporting expression of Peril in the brain and spinal cord of a heterozygote E14.5 
embryo. LGE/CGE, Lateral and Caudal Ganglionic Eminence; P, Pons; CP, Choroid Plexus; SC, Spinal Cord; D, dorsal; V, ventral; R, rostral;  
C, caudal. Scale bars = 1 mm, whole brains; 500 µm, sections. (G) Relative expression levels of Peril as assessed by RT-PCR and expression 
estimates (FPKM) of the neighboring genes Sox2 and Sox2ot as assessed by RNA-Seq in E18.5 brain of homozygote mutant and wild-type 
littermates (n = 2 each).
DOI: 10.7554/eLife.01749.006
The following figure supplements are available for figure 2:
Figure supplement 1. Peril E18.5 brain differential RNA-Seq analysis. 
DOI: 10.7554/eLife.01749.007
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noncoding RNA Sox2ot were not significantly affected in the knockout brains (Figure 2G). Differentially 
regulated genes and gene set enrichment analysis (GSEA) revealed downregulation of genes involved 
in cell cycle regulation, energy metabolism, immune response, and mRNA and protein processing in 
Peril−/− brains relative to wild-type controls (Figure 2—figure supplement 1B and C). This indicates 
that the transcriptional programs within the brain are in fact affected by deletion of Peril. Yet, it remains 
unclear if these changes underlie the observed lethality.
Fendrr−/− is perinatal lethal due to defects in multiple organs
Fendrr is a 2,380 bp transcript consisting of six exons. It is transcribed from a bidirectional promoter 
shared with the protein coding gene Foxf1a, located 1,354 bp from its transcriptional start site 
(Figure 3A). An orthologous human FENDRR (LINC–FOXF1) transcript expressed from a syntenic region 
was identified within our catalog of human lincRNAs (Cabili et al., 2011). We previously demonstrated 
that this lincRNA is predominantly nuclear and physically associates with the PRC2 Polycomb complex 
(Khalil et al., 2009).
To determine the onset of Fendrr lethality, we monitored the survival of embryos at both early and 
late stages of embryonic development, as well as that of newborn pups. Normal Mendelian ratios were 
found at both E14.5 and E18.5 (Figure 3B), with embryos appearing macroscopically normal prior 
to birth (Figure 3C), suggesting that the lethality most likely occurred after birth. Importantly, we 
observed 8 Fendrr−/− mutant newborns (P0) (Figure 3B), all of which died within 24 hr, indicating 
perinatal lethality.
During the course of our study, another group generated a Fendrr loss-of-function mouse model 
by replacing the first exon with multiple transcriptional termination sequences (Grote et al., 2013). 
In contrast to the results presented here, Grote et al. observed lethality at E13.75 due to heart and 
body wall (omphalocele) defects. When analyzing E14.5 embryos, we found no resorbed embryos or 
omphalocele in our Fendrr homozygous mutants (Figure 3—figure supplement 1). Although, both 
studies used similar genetic background strains, a possible explanation for this discrepancy may be 
found in the distinct targeting strategy used to remove the Fendrr gene. Regardless, both studies 
confirm that loss of Fendrr is lethal in mice.
Grote et al. observed Fendrr expression to be restricted to nascent lateral plate mesoderm and did 
not detect it in any other tissue. Using RNA-Seq expression profiling from adult mouse tissues and cell 
lines, we however found that Fendrr is expressed at high levels in the adult lung, and lower levels are 
detectable in colon, liver, spleen and brain (Figure 3D). Analysis of the knocked-in lacZ reporter in 
E14.5 and E18.5 embryos confirmed expression of Fendrr in these tissues as well as in the trachea and 
all along the gastrointestinal tract (Figure 3E,F). Interestingly, in the developing respiratory and digestive 
tracts at E14.5 and E18.5, expression of Fendrr is restricted to the pulmonary mesenchyme surrounding 
the bronchiolar epithelial cells (Figure 3E, right panels); in mesenchymal cells of the developing mucosa; 
the muscularis externa of the gut and in lymphoid aggregations within the gut’s mucosa (Figure 3F, 
bottom panel), all of which are derived from the lateral plate mesoderm.
Perinatal lethality is often associated with respiratory failure. Since the highest expression levels of 
Fendrr are found in the lungs, we evaluated initiation of breathing in surgically delivered E18.5 embryos. 
After cleaning of their airways, all Fendrr−/− embryos analyzed either failed to breathe or gasped and 
stopped breathing within 5 hr (n = 7 Fendrr−/−, Figure 3G). In contrast, respiration initiated normally 
and was maintained for all but one of the heterozygote and wild-type embryos (n = 15 Fendrr+/− and 
n = 8 wild type). Fendrr−/− lungs at the pseudoglandular stage (E14.5) were hypoplastic compared to 
wild type (Figure 3H), and histological evaluation of the lungs revealed a decrease in the number and 
organization of pulmonary arteries, and a general failure of vasculogenesis within the lungs of the 
Fendrr−/− mutants compared to wild type (n = 3 Fendrr−/− and n = 3 wild type; Figure 3I, upper panels). 
At E18.5, Fendrr−/− lungs appeared to have fewer but larger alveoli (n = 3 Fendrr−/− and n = 3 wild type; 
Figure 3I, lower panels). Together, these results suggest that respiratory failure observed at birth in 
Fendrr−/− mice could be due to a lung maturation and vascularization defect.
We also observed expression of Fendrr in the esophagus and gut. We observed thinning of the 
mesenchymal layer of the mucosa and external smooth muscle layers in the esophagus at E18.5 (n = 3 
Fendrr−/− and n = 3 wild type; Figure 3J). Although we did not observe Fendrr expression in the heart 
at E14.5, E18.5, or postnatally, we did observe intraventricular septal heart defects prior to birth 
(E18.5) (n = 3 Fendrr−/− and n = 3 wild type; Figure 3K). In accordance with Fendrr having a previously 
described role in lateral plate mesoderm (Grote et al., 2013), our results suggest a more general role 
Developmental biology and stem cells | Genes and chromosomes
Sauvageau et al. eLife 2013;2:e01749. DOI: 10.7554/eLife.01749 7 of 24
Research article
Figure 3. Fendrr−/− pups have multiple defects in lung, heart and gastrointestinal tract. (A) Fendrr locus and targeting strategy. Arrows indicate location 
of the primers used for genotyping. (B) Genotyping results from heterozygote intercrosses at embryonic stages E14.5, E18.5 and at birth (P0). The 
p value is based on X2 test. (*) All newborns died within 24 hr after birth. (C) Fendrr−/− E18.5 embryos and wild-type littermates. (D) RNA-Seq expression 
profile for Fendrr across a panel of mouse tissues and cell types. (E and F) lacZ reporter stained organs and sections showing expression of Fendrr in 
specific regions of the lung (Lu), trachea (Tr) and esophagus (Es), but not in heart (H) in E14.5 and E18.5 embryo (E) and in the gut and stomach (St) (F). 
Sm, smooth muscle; Ep, Epithelia; Me, Mesenchyme; Ly, Lymphoid aggregates. Scale bars = 1 mm whole organ, 200 µm sections. (G) Number of E18.5 
embryos successfully breathing after surgical delivery. (H) Size difference of Fendrr−/− lungs at E14.5 compared to wild-type littermates (n = 3 each). 
(I–K) Representative hematoxylin and eosin (H&E) stained sections showing unstructured vessels (arrow) in E14.5 Fendrr mutant lungs compared to wild 
type littermates (n = 3) (I, upper panels), alveolar defects at E18.5 (I, lower panel), thinner mesenchymal layer of the mucosa and external smooth muscle 
layer of the oesophagus (J) and ventricular septal defects in the heart (K) of Fendrr−/− E18.5 embryos compared to wild type (n = 3). Scale bars= 500 µm, 
100 µm for esophagus. (L) RNA-Seq expression levels of Fendrr and the neighboring coding gene Foxf1a in E18.5 lung of homozygote mutant and wild-type 
littermates (n = 2 each). (M) GSEA of Fendrr−/− vs wild-type E18.5 lung and total brain RNA. Each tile is a significant (q<0.001; Mann-Whitney, BH) gene 
set from the Reactome collection at mSigDB, based on the Fendrr−/−/wild-type ranking of test-statistic values from a Cuffdiff2 differential analysis. Tiles are 
shaded based on the z-score of the test-statistic for genes within the given gene set, relative to all genes for a given condition to show direction of 
expression relative to wild-type.
DOI: 10.7554/eLife.01749.008
The following figure supplements are available for figure 3:
Figure supplement 1. Fendrr−/− embryos don’t have an omphalocele. 
DOI: 10.7554/eLife.01749.009
Figure supplement 2. Fendrr, linc–Brn1b, and Peril do not act as cis-enhancer elements. 
DOI: 10.7554/eLife.01749.010
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for Fendrr in regulating the proper differentiation of mesenchyme-derived tissues across several organ 
systems.
We next investigated if neighboring gene expression is perturbed by the deletion of Fendrr. 
We harvested lungs from E14.5 Fendrr−/− embryos and wild-type littermates (n = 2) and performed dif-
ferential RNA-Seq analyses. A loss of Fendrr expression in knockout relative to wild-type lungs confirmed 
deletion of Fendrr (Figure 3L). No significant change in the expression of the Foxf1a protein coding 
gene was observed in the Fendrr−/− lung. Furthermore, genes within ±1 Mb of the Fendrr locus were not 
significantly differentially expressed any more than background levels of local enrichment (Figure 3—
figure supplement 2A, p<0.087; bootstrapped from random 2 Mb genomic intervals), suggesting that 
the Fendrr gene does not act as a local enhancer. GSEA identified gene sets involved in muscle differen-
tiation and contraction as the most significant sets misregulated in Fendrr−/− lungs compared to wild type 
(Figure 3M). This agrees with our identification of defects in the lung vasculature of the Fendrr−/− mice. 
Further studies will be needed to understand how specific changes in gene-expression patterns upon 
deletion of Fendrr contribute to the observed defects and perinatal lethality.
Ablation of distinct lincRNA genes affects mouse growth
To determine if deletion of our candidate lincRNAs affects normal development and growth postnatally, 
each strain was examined for gross morphological abnormalities and body weight (BW) measurements 
were taken. Homozygote mutant mice with heterozygote and wild-type littermate controls were compared 
over a 7–10 week period. Mdgt−/− pups displayed a severe growth retardation phenotype, which may con-
tribute to their lethality (Figure 4C,D). A week after birth, Mdgt−/− pups were already significantly 
smaller than heterozygote and wild-type littermates (Figure 4C), with females 60% smaller (n = 5, 
p<0.00001) than wild-type littermates (n = 10) and males 32% smaller (n = 3, p<0.05), suggesting a sex 
bias in this phenotype. In Mdgt−/− survivors, this retarded growth persisted up to 10 weeks in females, 
which were still 37% smaller than wild types (Figure 4D, p<0.0006). The defect, although milder, 
also persisted in male mutants up to at least 8 weeks.
Mdgt is a 443 bp transcript consisting of three exons transcribed from a bidirectional promoter 
shared with the homeobox gene Hoxd1. The first exon for Mdgt is located only 84 bp away from the 
Hoxd1 transcription start site. Another noncoding transcript, AK144266, is contained within an intron 
of Mdgt and appears to be expressed from the opposite strand (Figure 4A). In our targeting strategy, 
the entire Mdgt locus was deleted, including the AK144266 transcript (Figure 4A). Expression estimates 
obtained from RNA-Seq revealed that Mdgt is highly expressed in testes, and more moderately in 
brain, kidney, colon and skeletal muscles (Figure 4B). lacZ staining confirmed expression in those 
tissues and also revealed expression in stomach and thymus (Figure 4E).
In addition to Mdgt, stunted growth defects were also observed in three other strains (Figure 4—
figure supplement 1). 3 weeks after birth, linc–Pint−/− mice were noticeably smaller than wild-type 
littermates (Figure 4—figure supplement 1A). By 7 weeks of age, females had 22% reduced body 
weight (n = 5, p<0.001) compared to wild type (n = 4), whereas males were 29% smaller (n = 3 
linc–Pint−/−; n = 3 wild type, p<0.05). A decrease in body weight was also observed by three weeks of 
age in linc–Brn1b−/− (29%, p<0.013, n = 3) and Peril−/− mice (35%, p<0.0003, n = 4) when compared to 
wild-type littermates (n = 3) (Figure 4—figure supplement 1B,C). Together, these results indicate that 
specific lincRNAs can be important for normal body weight and growth.
Identification of developmentally regulated human lincRNA orthologs
In order to determine whether loss of our candidate lincRNAs could lead to other developmental defects, 
we examined additional mutant strains that did not show perinatal lethality. Building on prior evidence that 
lincRNAs are abundantly expressed and spatio-temporally regulated within the brain during development 
and adulthood (Mercer et al., 2008; Qureshi et al., 2010; Cabili et al., 2011; Ramos et al., 2013), 
we concentrated on the candidate lincRNAs that were expressed in the brain or in neural progenitors. 
Twelve of the lincRNAs for which we have established knockout strains exhibited such expression profile 
(Figure 1B). To focus on lincRNA candidates of potential functional relevance in neuronal development, 
we used syntenic orthology (TransMap [Zhu et al., 2007]) and RNA-sequencing to select those with 
identifiable human orthologs, and whose expression was regulated during in vitro neural differentiation.
Briefly, transcripts expressed along a time course of ES-derived human neural stem cells (NSC) dif-
ferentiation (Goff et al., 2009) (Figure 5A) were assembled and aggregated with an existing compen-
dium of RNA-Seq data, using our previously described lincRNA discovery pipeline (Cabili et al., 2011). 
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The resulting lincRNA catalog contained 24,737 distinct, high-quality transcript reconstructions corre-
sponding to 14,259 human lincRNA genes. We observed 769 lincRNA genes with significant differen-
tial expression (q<0.01; Cuffdiff2) between any two adjacent time points during NSC differentiation. 
With a false discovery rate of 1% (Figure 5—figure supplement 1), 302 of these were significantly 
induced relative to day 0 (Figure 5—figure supplement 1). This approach revealed that 7 lincRNAs 
from our mouse knockout strains have human orthologs that are dynamically induced during in vitro 
human neuronal differentiation (Figure 5B). Interestingly, two of these, linc–Brn1a and linc–Brn1b, 
were almost exclusively expressed in NSCs as determined by RNA-Seq (Figure 1B). These lincRNAs 
reside in the genomic region of Brn1 (Pou3f3), a well-studied transcription factor involved in cortical 
development (McEvilly, 2002; Sugitani et al., 2002; Dominguez et al., 2012). We thus focused on 
this locus, starting with linc–Brn1b, as it is not transcribed from a bidirectional promoter and therefore 
deletion does not disrupt the Brn1 promoter.
Linc–Brn1b expression is spatio-temporally restricted in the developing 
cerebral cortex
Using RNA-Seq data, we observed linc–Brn1b to be predominantly expressed in ES-derived NSCs with 
additional moderate expression in the adult brain and kidney (Figure 5C). The linc–Brn1b gene is a 
Figure 4. Mdgt−/− surviving mice have growth defects. (A) Mdgt genomic locus and targeting scheme. (B) RNA-Seq expression profile for Mdgt across a 
panel of mouse tissues and cell types. (C) Representative example showing the reduced size of Mdgt−/− pups compared to wild type 7 days after birth 
(P7). (D) Body weight (g) measurements over a 10 weeks period show growth retardation in both female and male Mdgt−/− mice compared to wild type 
and Mdgt+/− littermates (Females: n = 5 Mdgt−/−, n = 15 Mdgt+/− and n = 10 wild types; Males: n = 3 Mdgt−/−, n = 10 Mdgt+/− and n = 10 wild types). 
Significant p values at each time point are indicated (*). (E) Whole mount lacZ stainings reporting expression of Mdgt in adult tissues of heterozygote 
mutant mice. Scale bars = 1 mm, testis, thymus; 2 mm, brain, stomach, colon.
DOI: 10.7554/eLife.01749.011
The following figure supplements are available for figure 4:
Figure supplement 1. Growth retardation phenotype in lincRNA knockout strains. 
DOI: 10.7554/eLife.01749.012
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∼3 Kb transcript derived from a 6.8 Kb genomic locus approximately 10 Kb downstream of the Brn1 
protein coding gene. To generate the linc–Brn1b knockout mice, we targeted the entire linc–Brn1b 
locus (Figure 5D). Complete ablation was confirmed by qRT–PCR (Figure 5E) using adult brain cDNA 
as template. RNA-FISH in mouse E14.5 neural progenitor cells (NPCs) isolated from the cerebral cor-
tex demonstrated that the linc–Brn1b transcript is predominantly nuclear with moderate cytoplasmic 
expression (Figure 5F).
While identified as a lincRNA expressed in adult brain, the spatio-temporal distribution of linc–Brn1b 
during brain development is not known. Therefore, we used lacZ expression from the linc–Brn1b locus 
in heterozygote mutants to define its expression in vivo. We found that linc–Brn1b was expressed 
within neural progenitors of both the ventral and dorsal telencephalon, as early as E13.5 (Figure 5G). 
Figure 5. linc–Brn1b is spatio-temporally regulated during corticogenesis. (A) Schematic overview of the in vitro human neural stem cell differentiation 
protocol. RNA was collected at the indicated time points and sequenced to identify significantly differentially expressed lincRNA human orthologs.  
(B) Heatmap of log2 ratios to undifferentiated (Day 0) human neural stem cells for 7 of the 20 lincRNAs selected for deletion with a significant (q<0.01; 
Cuffdiff2) increase in expression during differentiation. (C) RNA-Seq expression profile for linc–Brn1b across a panel of mouse tissues and cell types. 
(D) linc–Brn1b genomic locus and targeting strategy. (E) qRT–PCR confirmation of the genotype for both heterozygotes (+/−) and homozygous null (−/−) 
mutants. (F) Single-molecule RNA FISH targeting linc–Brn1b in wild-type E14.5 cortical neurospheres. (G) lacZ staining shows expression profile of 
linc–Brn1b at different embryonic (E13.5, E15.5 and E18.5) and early postnatal stages (P7) in linc–Brn1b+/− telencephalon. lacZ expression in neural progenitors 
of both ventral telencephalon (lateral ganglionic eminence, LGE and medial ganglionic eminence, MGE) (E13.5) and dorsal telencephalon (ventricular zone, VZ 
and subventricular zone, SVZ) (E15.5) is detected. Restricted expression in the upper cortical layers is observed in both E18.5 and P7 cortex. (H) Whole mount 
lacZ staining of P7 linc–Brn1b+/− brain shows distinct linc–Brn1b expression in primary somatosensory (S1) and visual (V1) cortical areas. (I) β-galactosidase 
immunofluorescence on coronal sections of P7 linc–Brn1b−/− cortex shows linc–Brn1b expression in layer IV of the somatosensory area (white boxes), 
specifically within the barrel structures (white arrows), as determined by co-staining with the upper layer markers SATB2 and CUX1. Abbreviations: LV, lateral 
ventricle; LGE, lateral ganglionic eminence; MGE, medial ganglionic eminence; CGE, caudal ganglionic eminence; CP, cortical plate; SVZ, subventricular zone; 
VZ, ventricular zone; Str, striatum; M1, primary motor area; S1, primary somatosensory area; cc, corpus callosum; V1, primary visual cortex; A1, primary 
auditory cortex; F/M, frontal motor cortex. Scale bars: 500 µm (G), (I, upper panels); 100 µm (I, lower panels).
DOI: 10.7554/eLife.01749.013
The following figure supplements are available for figure 5:
Figure supplement 1. Differential expression of protein coding genes, lncRNAs and neuronal markers during human ES-derived neuronal differentiation 
time course. 
DOI: 10.7554/eLife.01749.014
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Detailed characterization of expression in the germinal zones of the dorsal telencephalon showed that 
by E15.5, it was strongly expressed in progenitors of both the ventricular zone (VZ) and the subventricular 
zone (SVZ) of the developing cerebral cortex, and by E18.5 showed restricted expression in the developing 
upper cortical layers. In addition, whole-mount lacZ staining at P7, showed a specific areal distribution 
for linc–Brn1b within both the primary somatosensory cortex and the primary visual cortex (Figure 5H). 
Within the somatosensory cortex, linc–Brn1b was expressed in the barrel structures of the posteromedial 
barrel subfield (PMBSF) (Figure 5I); a highly organized region of cortical projection neurons that receives 
afferent connections from the thalamus and is responsible for the coordination of sensory inputs from 
the rodent vibrissae (Petersen, 2007).
Collectively, the timing and location of linc–Brn1b expression within the developing cortex suggests 
a potential role for linc–Brn1b in area-specific development of distinct classes of projection neurons.
Loss of linc–Brn1b results in specific reduction in the number of 
intermediate progenitor cells (IPCs) in the cerebral cortex
To investigate the consequences of genetic deletion of linc–Brn1b during development of the 
telencephalon, we performed RNA-Seq on E13.5 and E15.5 whole telencephalons and P7 whole 
brains (n = 2) of wild type and linc–Brn1b−/− mice. At all time points, RNA-Seq analyses identified a 
statistically significant reduction (∼50%) in expression of the neighboring Brn1 protein coding gene in 
linc–Brn1b−/− brains relative to wild type (E15.5 shown in Figure 6A, Figure 6—figure supplement 1A,B). 
We observed a similar decrease in BRN1 protein expression between wild type and linc–Brn1b−/− 
E14.5 cortical-derived neurospheres and E15.5 whole cortex samples (Figure 6B). In contrast, upon 
knockout of linc–Brn1b, we observed a significant increase in expression of linc–Brn1a (p<0.01; Cuffdiff2), 
which shares a bidirectional promoter with Brn1 (Figure 6A). This suggests opposing regulatory effects 
on the neighboring lincRNA and protein coding genes upon deletion of linc–Brn1b.
Gene set enrichment analysis (GSEA) revealed a significant decrease in genes associated with 
cellular growth and proliferation in linc–Brn1b−/− relative to wild type at all three time points sampled 
and an increase in gene sets positively correlated with neuronal maturation (Figure 6C). These results 
are consistent with a predicted role for linc–Brn1b derived from our initial GBA analyses (Figure 1C) 
and suggest a function for linc–Brn1b in the differentiation of neural progenitors and neurogenesis in 
the telencephalon.
To investigate potential abnormalities of linc–Brn1b−/− mutants, we concentrated on the dorsal 
telencephalon (the developing cerebral cortex). First, to quantify the proliferation of cortical progenitors, 
we evaluated the expression of the mitotic marker phosphorylated histone H3 (pH3) in E15.5 wild type 
and linc–Brn1b−/− cortices (Figure 6D). Quantification of pH3+ cells revealed a significant and specific 
reduction in the relative percentage of pH3+ intermediate progenitor cells within the SVZ (36.88% 
decrease; p<3.93e-05; Student’s t test) in linc–Brn1b mutant vs control cortices (Figure 6E). The observed 
abnormalities were specific to intermediate progenitors, as there was no statistically significant change 
in the proliferation rate of apical progenitors within the VZ (Figure 6E).
In agreement with a reduction in intermediate progenitors of the cortical SVZ we found decreased 
expression of the markers TBR2 (Figure 6F), Cux2 (Figure 6G), and Svet1 (Figure 6H) (Tarabykin 
et al., 2001; Zimmer, 2004; Molyneaux et al., 2007; Arnold et al., 2008; Cubelos et al., 2008; 
Sessa et al., 2008) in linc–Brn1b−/− mutants.
Together, the data indicate that linc–Brn1b knockout mice exhibit a decrease in proliferation of 
cortical progenitors in vivo, and that this defect is restricted to a specific subpopulation of progenitors 
in the SVZ of the developing cortex.
Cortical lamination is abnormal in linc–Brn1b−/− mice
To investigate whether the observed decrease in SVZ progenitors resulted in an overall reduction in cortical 
thickness, we measured linc–Brn1b−/− mutants and wild-type littermates at P7. The distance between 
the pia and the white matter was measured at matched medio-lateral and rostro-caudal locations (n = 17 
wild-type sections and n = 10 linc–Brn1b−/− sections). We reproducibly observed a significant 6.24% 
decrease in the total thickness of the neocortex in the mutants, relative to wild type (1317.31 µm ± 
20.03 in linc–Brn1b−/− vs 1404.90 µm ± 15.07 in wild type; p<0.002, Student’s t test) (data not shown).
To define whether generation of projection neuron subtypes was affected in the absence of linc–
Brn1b, cortices from linc–Brn1b−/− and wild-type littermates were collected at P7 and immunostained 
for markers of different projection neuron classes: CUX1, a marker of upper layer II/III and IV callosal 
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projection neurons (Zimmer, 2004) (Figure 7A), CTIP2, a marker of layer V subcerebral projection neurons 
(Arlotta et al., 2005) (Figure 7B), and TLE4, a marker of layer VI corticothalamic projection neurons (Koop 
et al., 1996; Chen, 2005; Molyneaux et al., 2005) (Figure 7C). Measurements of the thickness of each 
cortical layer showed a distinct reduction in the upper layer II/III–IV (11.62% reduction in absolute thickness 
in linc–Brn1b−/− vs wild type; Figure 7A, p<0.0004; Student’s t test), which was also detectable by histolog-
ical Nissl staining (Figure 7D). In contrast, no significant change in the absolute thickness of either layer 
V (Figure 7B, p<0.18; Student’s t test) or VI (Figure 7C, p<0.54; Student’s t test) was detected.
In order to determine whether the number of specific classes of neurons within layers was affected 
in the mutant cortex, we quantified the percentage of CUX1+, CTIP2+ and TLE4+ neurons. In agreement 
with a reduction in the thickness of layer II/III–IV, we observed that the number of CUX1+ callosal 
Figure 6. linc–Brn1b−/− mice demonstrate defects in proliferation of IPCs. (A) RNA-Seq expression estimates from E15.5 wild type and linc–Brn1b−/− 
telencephalon for linc–Brn1b, the protein coding gene Brn1, and neighboring genes linc–Brn1a and 2900092D14Rik. (B) Western blots of wild type and 
linc–Brn1b−/− E14.5 cortical neurospheres (NS), and E15.5 cortices. (C) GSEA of linc–Brn1b−/− vs wild type in E13.5 and E15.5 telencephalon and P7 whole 
brain (as described in Figure 3). (D and E) Immunofluorescence staining for the mitotic marker phosphorylated histone H3 (pH3) in E15.5 coronal sections 
of cortex (D) and pH3+ cell counts of apical  progenitors (APC) and intermediate progenitors (IPC) (E). (F–H) Immunofluorescence staining for TBR2 (F), 
and in situ hybridization for Cux2 (G) and Svet1 (H) in wild type and linc–Brn1b−/− E15.5 cortex show that mutant mice have decreased expression of 
SVZ intermediate progenitor markers. Scale bars = 500 µm (D–H). **p<0.01, ***p<0.001; Student’s t test. LGE, lateral ganglionic eminence; LV, lateral 
ventricule; ctx, cortex; CP, cortical plate; VZ, ventricular zone; SVZ, subventricular zone; IZ, intermediate zone.
DOI: 10.7554/eLife.01749.015
The following figure supplements are available for figure 6:
Figure supplement 1. Brn1 transcript is reduced in linc–Brn1b−/− E13.5 telencephalon and P7 brain. 
DOI: 10.7554/eLife.01749.016
Developmental biology and stem cells | Genes and chromosomes
Sauvageau et al. eLife 2013;2:e01749. DOI: 10.7554/eLife.01749 13 of 24
Research article
projection neurons was decreased by 12.97% in the mutant compared to wild type (Figure 7A, 
mean = 1137 ± 69 CUX1+ cells in linc–Brn1b−/− vs mean = 1307 ± 52 in wild type; p<0.03; Student’s 
t test). Conversely, despite the unchanged thickness of layers V and VI, the number of CTIP2+ subcer-
ebral projection neurons (Figure 7B, mean = 271 ± 28 in linc–Brn1b−/− vs mean = 199 ± 14 in wild type; 
p<0.016; Student’s t test) and TLE4+ corticothalamic projection neurons (Figure 7C, mean = 1432 ± 37 
in linc–Brn1b−/− vs mean = 1176 ± 31 in wild type; p<5.9 × 10−5; Student’s t test) neurons were increased 
by 36.39% and 21.77% in the linc–Brn1b−/− mice, respectively. These data suggest the possibility that 
a subset of upper layer progenitors abnormally generate deep layer neurons in place of CUX1+ upper 
layer neurons in the linc–Brn1b−/− mutant.
The selective reduction in the generation of upper layer cortical neurons is interesting, consid-
ering that these neurons are principally derived from the expansion of intermediate progenitors, 
which are reduced in linc–Brn1b−/− mice. Taken together, these results indicate that linc–Brn1b is 
required for proper generation of cortical neurons, in particular projection neurons of layer II/III–IV.
Figure 7. Abnormal cortical lamination and disruption of the barrel cortex in linc–Brn1b−/− mice. (A) Immunofluoresence staining and quantification on 
coronal sections of P7 wild type and linc–Brn1b−/− cortices for upper layer II–IV marker CUX1 show a significant reduction in absolute layer thickness 
and total number of CUX1+ projection neurons in linc–Brn1b−/− mice. (B and C) Immunofluorescence staining and quantification on coronal sections 
of P7 wild type and linc–Brn1b−/− cortices for layer V marker CTIP2 (B), and for layer VI marker TLE4 (C) show not significant change in the total 
thickness of layer V and VI, but significant increase in the number of CTIP2+ subcerebral projection neurons and TLE4+ corticothalamic neurons in 
linc–Brn1b−/− mice. (D) Nissl staining of coronal sections of P8 wild type and linc–Brn1b−/− cortices shows overall cortical reduction and specific 
decrease in upper layer thickness in linc–Brn1b−/− mice. (E) Rorβ in situ hybridization on coronal sections of P7 wild type and linc–Brn1b−/− primary 
somatosensory cortex. (F) Cytochrome oxidase c activity on sections spanning barrel cortex shows reduction in the anteriolateral barrel subfield (ALBSF) 
in linc–Brn1b−/− mice. The loss of barrels in the ALBSF and their general disorganization are confirmed by immunofluorescence staining for vGLUT2 (G) 
and 5-HTT (H). The full arrows indicate individual barrels and arrowheads point to corresponding barrels that are absent in the linc–Brn1b−/− brains. 
*p<0.05, **p<0.01, ***p<0.001; Student’s t test. Scale bars = 500 µm (A–E) and (G–H), 100 µm (F). ctx, cortex; cc, corpus callosum; str, striatum; PMBSF 
and ALBSF, posteriomedial and anteriolateral barrel subfield.
DOI: 10.7554/eLife.01749.017
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Disorganization of the barrel cortex in linc–Brn1b−/− mice
Whole mount analysis of linc−Brn1b areal distribution showed high levels of expression in primary 
somatosensory cortex, an area that in rodents receives thalamocortical afferents relaying sensory 
information from the mustacial vibrissae (Petersen, 2007). Given the expression of linc–Brn1b within 
this region, and the requirement for proper specification of upper layer neurons, we investigated 
whether linc–Brn1b is required for the proper development of the somatosensory cortex and organi-
zation of the barrel structures. In situ hybridization against the barrel cortex marker RAR-related orphin 
beta (Rorβ) (Jabaudon et al., 2012), on matched coronal sections of P7 wild type and knockout mouse 
cortices demonstrated a reduction in the total size of the barrel cortex in the linc–Brn1b−/− mice (Figure 7E) 
with a more pronounced loss of Rorβ+ neurons at the medial edge.
Histochemical staining of cytochrome oxidase C activity in the somatosensory cortex was exam-
ined and showed a distinct disruption of the individual barrel structures, particularly within the ante-
riolateral barrel subfield (ALBSF) (Figure 7F). A reduction in overall area and number of barrels in 
linc–Brn1b mutants was also observed in the highly organized posteriomedial barrel subfield (PMBSF). 
These findings, already consistent with the Rorß in situ hybridization data, were confirmed in P7 cor-
onal sections immunostained with vGLUT2 (Figure 7G) and 5-HTT (Figure 7H), both of which spe-
cifically label the barrel structures. Analysis of both of these markers corroborates a specific impairment 
of the barrels within the ALBSF, and a general disorganization of individual barrel structures in the 
linc–Brn1b−/− mice.
Taken together, these results demonstrate the requirement of linc−Brn1b for the proper devel-
opment of different classes of projection neurons within the cerebral cortex, and suggest that the 
loss of linc−Brn1b may potentially have broader implications for state-dependent cortical sensory 
processing.
Discussion
In the post genomic era, thousands of long noncoding RNAs have been discovered as transcribed 
units in mammalian genomes. However, what fraction of these new transcripts have general functional 
significance in vivo is debated. While several studies have indicated a role for lincRNAs in diverse 
biological processes (Ponting et al., 2009; Rinn and Chang, 2012; Mercer and Mattick, 2013; 
Ulitsky and Bartel, 2013), it has been suggested that most transcripts could represent nonfunctional 
transcriptional by-products (Struhl, 2007; Kowalczyk et al., 2012). Early critical studies of knockout 
strains (e.g., Xist and Tsix) did find lncRNAs implicated in X inactivation to be required for life. Yet, 
of the relatively few lncRNA mouse models derived since, many have displayed subtle defects or 
no phenotype (Ripoche et al., 1997; Gordon et al., 2010; Anguera et al., 2011; Nakagawa et al., 
2011; Zhang et al., 2012).
Other strategies using RNAi and xenografts to assess the function of lncRNAs in vivo have revealed 
interesting roles in development and tumor growth (Ulitsky et al., 2011; Wang et al., 2011; Yang 
et al., 2013). Together with difficulties in finding a phenotype in mouse models such as Malat1, Neat1 
(Nakagawa et al., 2011; Zhang et al., 2012), these findings have led some to suspect that acute 
inactivation of lncRNAs leads to stronger phenotypes than constitutive deletions, where compensatory 
events may occur. Therefore, our study, grounded in genetic deletions, demonstrates the important 
physiological insights that can be gleaned by constitutive lincRNA knockouts.
By leveraging our large-scale RNA-sequencing and genomics studies in combination with an inte-
grated and multifaceted candidate selection pipeline, we were successful in finding physiologically 
essential lincRNAs. Through the initial characterization of the 18 lincRNAs knockout strains generated 
here, we found three that exhibit peri- or post-natal lethality and two additional ones with distinct 
developmental defects. Future studies will describe in detail other promising phenotypes.
A few recent studies have demonstrated that lincRNAs regulate neighboring protein coding genes 
and thereby may function as cis-enhancers or cis-regulatory elements (Ørom et al., 2010; Wang et al., 
2011). Here, we were able to examine several lincRNAs and the regulation of the neighboring protein 
coding genes in a genetically defined context. We find one instance where the deletion of a lincRNA, 
Fendrr, phenocopies the neighboring protein coding gene despite a non-significant effect on Foxf1 
gene expression. Interestingly, chromatin predictions of enhancers (Shen et al., 2012) suggest this 
lincRNA may have enhancer-like properties (H3K4me1 and Pol II). However, our genetic analysis is not 
consistent with the notion of Fendrr as a chromatin signature-defined ‘enhancer’. Specifically, Grote 
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et al observed a similar lethality phenotype in Fendrr mutants, yet their strategy (insertion of a strong 
transcription stop sequence) retained almost the entire DNA segment of Fendrr. This suggests that 
Fendrr cannot be acting simply as a DNA enhancer, although we cannot rule out the passive act of 
transcription as being functional. In our model, both the endogenous promoter and first exon remain. 
Moreover, the introduced lacZ reporter is actively transcribed as well, thus ruling out the passive act 
of transcription for Fendrr activity. Finally, since this lincRNA does not appear to act as a local enhancer 
and does not encode a small peptide based on PhyloCSF and Ribosome profiling analyses, we believe 
Fendrr to be a physiologically relevant and functional RNA molecule.
Interestingly, Fendrr mutant mice exhibit many features of Foxf1a protein coding gene heterozy-
gous mutants (Mahlapuu et al., 2001). Since we do not observe a significant decrease in Foxf1a 
expression in Fendrr mutants, this raises the possibility that Fendrr could act downstream of Foxf1a. 
The FOXF1A protein plays an important role in the development of the lung and the gastrointestinal 
tract (Mahlapuu et al., 2001). Similarly, we found that Fendrr is expressed in the mesenchyme of these 
tissues and that homozygote mutant mice display lung and gastrointestinal tract defects most likely 
leading to perinatal lethality. Several cases of genetic deletions encompassing the neighboring protein 
coding gene FOXF1, and also FENDRR have been observed in neonates with the lethal lung disorder 
‘alveolar capillary dysplasia with misalignment of pulmonary veins’ (ACD/MPV) (Szafranski et al., 2013). 
This supports our hypothesis that lincRNAs can be required for normal organ development and 
misregulated in pathological states, which could translate to human disease.
Deletion of both Peril and Mdgt also results in viability defects. Mdgt is transcribed from a bidirec-
tional promoter shared with Hoxd1, which is located only 84 bp away from Mdgt. Although we do not 
exclude that Hoxd1 expression could be affected by our Mdgt deletion strategy, the phenotype of 
homozygous Hoxd1 mutants, which are viable and fertile, is in sharp contrast with Mdgt−/− mutants 
(Guo et al., 2010). Thus, deletion of Mdgt does not phenocopy Hoxd1, indicating a distinct function 
for this lincRNA. Interestingly, mice with a deletion of the adjacent Hoxd3 protein coding gene display 
reduced viability similar to Mdgt (Condie and Capecchi, 1993). However, contrary to Mdgt−/−, the 
surviving Hoxd3−/− mice do not appear to have a growth defect, again suggesting a distinct function 
for Mdgt.
Neither the Peril nor Mdgt locus appears to be enriched for the signature enhancer modifications 
H3K4me1, H3K27ac in any public mouse ENCODE datasets. In the case of Peril, no genes were found 
significantly differentially expressed in knockout vs wild-type brains within ±1 Mb of Peril (Figure 3—
figure supplement 2C; p<1.0, bootstrapped from 1000 random genomic intervals). Therefore, cis 
effects, as suggested by other enhancer-associated lincRNAs like Hottip (Wang et al., 2011), are 
unlikely. Collectively, these results suggest that lethality of the three lincRNAs observed in this study 
are likely not due to cis or enhancer-like RNA regulatory effects.
In addition to viability phenotypes, we also describe several developmental abnormalities such as 
body size and cortical defects in the linc–Brn1b mutant strain. Based on currently available public 
data, the linc–Brn1b locus does not appear to have enrichment for chromatin marks characteristic of 
enhancers, but rather the canonical H3K4me3/H3K36me3 signature of active transcription in the 
brain. In this case, however, deletion of linc–Brn1b did affect the expression of the neighboring 
protein coding gene. linc–Brn1b resides near Brn1 (Pou3f3), a key transcription factor that shares 
redundant roles with the closely related paralog Brn2 (Pou3f2) in upper layer cortical development. 
Interestingly, deletion of linc–Brn1b results in a significant reduction in the neighboring BRN1 pro-
tein (Figure 6). However, in contrast to linc–Brn1b mutants, deletion of Brn1 alone does not lead to 
defects in cortical lamination. Only when both Brn1 and Brn2 are deleted (Brn1/2 double mutants) 
is a reduction in layers II–IV neurons observed (McEvilly, 2002; Sugitani et al., 2002; Dominguez 
et al., 2012). Despite the differential regulation of the adjacent Brn1 gene, linc–Brn1b does not 
appear to act as a general cis-enhancer. The region has five other genes within ±1 Mb that are dif-
ferentially expressed. However, this is not significant given the dramatic changes to the transcriptome 
in the linc–Brn1b−/− E13.5 telencephalon (Figure 3—figure supplement 2B; p<0.225, bootstrapped 
from 1000 random genomic intervals).
We do not observe a significant difference in expression of the paralogous Brn2 protein coding 
gene in any linc–Brn1b−/− developmental stage analyzed when compared to wild type (Figure 6—
figure supplement 1C), Thus, despite an observed decrease in Brn1 expression in linc–Brn1b−/−, deletion 
of linc–Brn1b does not phenocopy deletion of the neighboring protein coding gene Brn1. In fact, 
ablation of linc–Brn1b results in a stronger phenotype than that observed for the neighboring protein 
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coding gene, suggesting additional roles for this lincRNA. In addition, we observe expression of 
linc–Brn1b in regions of the brain with no known expression of Brn1. Together, these observations 
suggest that lincRNAs adjacent to important developmental regulators may act on upstream and/or 
distinct pathways in addition to already reported cis-enhancer-like mechanisms (Ørom et al., 2010; 
Wang et al., 2011).
Further leveraging our genetically defined deletion we gleaned additional insights into lincRNA 
biology and transcriptional regulation in vivo. It has been noted that lincRNAs have a propensity to be 
transcribed from bidirectional promoters (Cabili et al., 2011; Pauli et al., 2012; Ulitsky and Bartel, 
2013). New studies have also suggested that many lincRNAs transcribed from bidirectional promoters 
are unstable and likely non-functional transcripts (Almada et al., 2013; Sigova et al., 2013). 
Interestingly, Fendrr is transcribed from a bidirectional promoter. Here, we observe that deletion of 
Fendrr is lethal despite leaving an intact promoter, expression of the first exon and not interfering with 
Pol II dynamics at this locus. Similarly, RNA-Seq analysis of linc–Brn1b knockout revealed a strong and 
significant upregulation of linc–Brn1a, a lincRNA transcribed from a bidirectional promoter shared with 
Brn1. This incongruous activity on adjacent genes (decrease in Brn1 protein coding gene and increase 
in linc–Brn1a transcribed from a bidirectional promoter with Brn1) observed in the linc–Brn1b−/− brain 
is suggestive of a functional role for the dynamically regulated linc–Brn1a, rather than transcriptional 
noise from bidirectional transcription from the protein coding gene promoter. Together, these findings 
confirm that not all lincRNAs transcribed from a bidirectional promoter are irrelevant transcriptional 
by-products, but rather suggests that some fraction of these transcripts play critical functional roles 
during development.
Our framework for lincRNA candidate selection for genetic analysis, based on RNA-sequencing 
catalogs and genomic studies, has led us to unexplored roles for lincRNAs in brain development. 
The brain (and the CNS more broadly) constitutes one of the most complex and fast evolving organs 
in the body. Here, it is likely that complex regulatory mechanisms of lincRNAs have evolved to build 
the layered control of gene expression necessary to generate the unparalleled cellular diversity and 
complex function of this organ. linc–Brn1b represents an example of a lincRNA that has an effect on 
development of the cerebral cortex. Beyond linc–Brn1b, many more lincRNAs from our screen have 
similar restricted patterns within progenitors in the VZ and SVZ of the telencephalon, possibly suggesting 
roles in neurogenesis. Others have highly cell-specific and dynamic in vivo expression patterns in distinct 
regions of the brain (Mercer et al., 2008). Thus, it is likely that more extensive work will reveal addi-
tional lincRNA mutants strains with additional brain and/or behavioral defects yet unexplored here. 
While rigorous behavioral studies will, in the future, determine whether loss of a lincRNA may result in 
specific behavioral abnormalities, we have made promising initial observations on two mutant strains. 
One mutant strain (Spasm) has tremors and a propensity to develop spastic movements upon handling, 
while a second strain (linc–p21) displays clasping of hind limbs when lifted by the tail (Sauvageau et al., 
unpublished).
As a whole, our 18 lincRNA knockout mouse models have revealed important aspects of lincRNA 
biology and constitute a useful resource for many future studies on the roles of lincRNAs in mammalian 
development, physiology and behavior.
Materials and methods
Mice
lincRNA knockout mice were generated by replacing the selected lincRNA gene with a lacZ cassette. 
Briefly, targeting constructs were constructed using VelociGene technology as described previously 
(Valenzuela et al., 2003). The VelociGene Allele Identification Numbers are shown in Supplementary 
file 1A. Linearized targeting constructs, generated by gap repair cloning containing mouse lincRNA 
upstream and downstream homology arms flanking a KOZAK-ATG-lacZ-pA-LoxP-hUb1-EM7-
neo(superscript R)-pA-LoxP cassette, were electroporated into VGF1 hybrid mouse embryonic stem 
(ES) cells, derived from a 129S6S v/Ev female to a C57BL/6N male mating. Mouse ES cells carrying 
a heterozygous deletion of the lincRNA gene were identified by loss-of-function allele screening with 
2 Taqman qPCR assays (Supplementary file 1F). Simultaneous replacement of the lincRNA gene with 
the lacZ cassette was confirmed by gain-of-allele Taqman assays against the lacZ and neomycin resist-
ance cassette (Supplementary file 1F). Probes were labeled with 6-carboxy-fluorescein (FAM) on their 
5′ ends and BHQ-1 on their 3′ ends. Targeted ES clones were introduced into an 8-cell stage mouse 
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embryo using the VelociMouse method (Poueymirou et al., 2006). Mice were backcrossed once with 
C57BL/6J. Mutant mice were identified by genotyping for loss of lincRNA allele and gain of lacZ 
cassette. Toe clips, embryos or yolk sac were digested for 30 min at 95°C in 100 μl of 25 mM Sodium 
Hydroxide and 0.2 mM EDTA. Tissue digestion was neutralized by adding 100 μl of 40 mM Tris-HCl. 
PCR reactions using 4 μl of digested tissue with 10 mM lacZ specific and lincRNA gene specific primer 
pairs (Supplementary file 1C for sequences) were then performed and run on a 2% agarose gel. PCR 
conditions were as follows: 5 min at 95°C followed by 35 cycles of 30 s at 95°C, 45 s at 60°C, 30 s at 
72°C and a final step at 72°C for 2 min. Mice were housed under controlled pathogen-free conditions 
(Harvard University’s Biological Research Infrastructure) and experiments were approved by the Harvard 
University Committee on the Use of Animals in Research and Teaching. Viability of the 18 lincRNA 
mutant strains was determined at postnatal day 21 by genotyping the progeny of heterozygous inter-
crosses (Supplementary file 1C for genotyping primer sequences). In the case of lethal strains, the 
developmental stage at which lethality occurs was determined by genotyping of embryos at E14.5 and 
E18.5 and newborns. Respiratory function (Fendrr mutant strain) was evaluated in surgically delivered 
E18.5 embryos from heterozygous intercrosses (Eggan et al., 2001). After cleaning of the airways, 
pups were placed on a 37°C warm pad and observed for sign of breathing.
RNA isolation and mRNA-Seq library preparation
Total RNA from embryonic and postnatal mouse tissues, neural stem cells, and neurospheres was 
isolated using TRIzol (Life Technology, Carlsbad, CA)/chloroform extraction followed by spin-column 
purification (RNeasy mini kit, Qiagen, Venlo, Netherlands) according to the manufacturer instructions. 
RNA concentration and purity were determined using a Nanodrop (Thermo Fisher, Waltham, MA). 
RNA integrity was assessed on a Bioanalyzer (Agilent, Santa Clara, CA) using the RNA 6000 RNA 
chip. High-quality RNA samples (RNA Integrity Number ≥8) were used for library preparation. mRNA-
seq libraries were constructed using the TruSeq RNA Sample Preparation Kit (Illumina, San Diego, CA) 
as previously described (Trapnell et al., 2012a; Sun et al., 2013). 500 ng total RNA was used as input 
for the TruSeq libraries from mouse tissues, and 200 ng for the libraries from neural stem cells and 
neurospheres. Prior to sequencing, libraries were run on a Bioanalyzer DNA7500 chip to assess purity, 
fragment size, and concentration. Libraries free of adapter dimers and with a peak region area 
(220–500 bp) ≥80% of the total area were sequenced. Individually barcoded samples were pooled and 
sequenced on the Illumina HiSeq 2000 platform.
RNA-Seq analysis
Paired-end 101 bp reads were aligned to the mouse (mm9) reference genome assembly and, for the 
human neuronal differentiation time course also to the human (hg19) assembly, using Tophat2 (Trapnell 
et al., 2009) with default options and assembled into transcripts with Cufflinks (Trapnell et al., 2012a, 
2012b). Aligned reads and assembled transcriptome catalog were used as input for Cuffdiff2 (Trapnell 
et al., 2012a) to determine expression levels (FPKM, Fragments Per Kilobase per Million mapped 
reads) and differential expression between conditions using default options. CummeRbund v2.1 
(http://compbio.mit.edu/cummeRbund/) was then used to process, index, and visualize the output 
of the Cuffdiff2 analyses. Gene set enrichment analysis (GSEA) and Guilt-by-Association analysis 
(GBA) were performed to predict the effect of gene expression changes on biological processes. 
Detailed description of GSEA and GBA analysis, RNA isolation, and libraries preparation are pro-
vided in the Extended Experimental Procedures. Cis-enhancer activity was tested by determining the 
number of genes with differential expression in a particular Knockout vs wild type contrast within 
±1 Mb window of the targeted lincRNA. 1000 random genomic intervals of the same size were 
obtained and interrogated in kind to determine how often the same number of differentially expressed 
(DE) genes could be identified. The ratio of intervals with DE genes >= the number of DE genes in the 
target-flanking window to the number of iterations, provided a bootstrapped p value and false dis-
covery rate estimate.
Gene set enrichment analysis (GSEA) and Guilt-by-Association (GBA) 
analysis
GSEA was performed to predict the effect of the significant gene expression changes on biological 
processes in the knockout mice. For a given comparison of KO vs WT differential expression, all genes 
were rank-ordered by their Cuffdiff2 test-statistics and mouse gene identifiers were mapped to human 
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HUGO gene names. Genesets from the Reactome collection at mSigDB were obtained and for each 
gene set, the relative enrichment or depletion within our ranked list was determined via Mann-Whitney 
U-test. p values were corrected for multiple tests using the Benjamini-Hochberg method. Genesets 
with q<0.001 were selected and presented as a heatmap with color mapped to the Z-score of the 
Cuffdiff2 test statics for genes in the specific gene set relative to all genes. Redundant genesets were 
aggregated into higher-level biological processes.
Predictive GBA analysis for 17/18 tested lincRNAs was conducted as follows: Pearson correlation 
values of FPKM expression profiles were calculated for each lincRNA to all protein coding genes across 
a compendium of RNA-Seq samples (combination of in-house samples and samples from [Merkin et al., 
2012]). Protein coding genes were then rank-ordered and subjected to the gene set enrichment analysis 
described above. Significant genesets for a given lincRNA represent the most likely pathways/biological 
processes for which this lincRNA may play a role.
lacZ expression and histology
Expression of the knocked-in lacZ reporter gene was assessed in heterozygous mice. Embryos (from 
E13.5 to E18.5) were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) overnight 
at 4°C prior to dissection of the brain, lung and respiratory tract, digestive tract, heart, and other 
organs. P7 brain, from linc–Brn1b mutant strain, were dissected from pups transcardially perfused with 
4% paraformaldehyde (PFA), and fixed overnight at 4°C. The fixed tissues were rinsed three times at 
room temperature in PBS, 2 mM MgCl2, 0.01% deoxycholic acid, 0.02% NP-40. X-gal staining was 
performed by incubating the tissues for up to 16 hr at 37°C in the same buffer supplemented with 5 
mM potassium ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml X-gal. Staining reaction was 
stopped by washing three times in PBS at room temperature, followed by 2 hr post-fixation in 4% 
PFA at 4°C. Stained whole organs and sagittal brain sections were imaged using a Leica M216FA 
stereomicroscope (Leica Microsystems, Buffalo Grove, IL) equipped with a DFC300 FX digital imaging 
camera (Watson et al., 2008). Histology was performed at the Rodent Histopathology Service of the 
Dana Farber/Harvard Cancer Center Pathology Research Core. Embryos were harvested, fixed in Bouin’s 
solution and embebbed in paraffin. Microtome sections were stained with hematoxilin and/or eosin for 
histological analysis.
Nissl staining and immunocytochemistry
Embryonic brains, dissected in cold PBS and fixed in 4% PFA/PBS overnight at 4°C, and P7 brains 
dissected from pups transcardially perfused with 4% PFA and post-fixed as described above, were 
processed for Nissl staining and immunofluorescence as previously described (Englund et al., 2005; 
Molyneaux et al., 2005). Nissl-stained and immunostained sections were imaged using a Nikon 90i 
fluorescence microscope equipped with a Retiga Exi camera (Q-IMAGING, Surrey, Canada) and acquired 
with Volocity image analysis software v4.0.1 (Perkin Elmer, Waltham, MA). For quantification of overall 
cortical thickness, cortical layers and number of CUX1+, CTIP2+ and TLE4+ cells within the primary 
somatosensory cortical area, anatomically matched sections were processed (n = 3 linc–Brn1b−/−; n = 3 
wild-type, at P7). Boxes of 300 pixels in width and spanning the thickness of the cortex were super-
imposed at matched locations on each section, and the overall cortical thickness was measured as 
the distance from the pia to the white matter in each box, using ImageJ. Specific layer thicknesses 
were measured at the midpoint of the matched-location 300 pixel images for each of the TLE4+, 
CTIP2+ and SATB2+ immunofluorescence stainings using ImageJ. Layer VI thickness was measured as 
the distance between the dorsal edge of the TLE4+ region and the white matter. Layer V thickness was 
determined by the span of the CTIP2+ region, and layer II–IV thickness were measured as the SATB2+ 
region between the dorsal edge of the CTIP2+ stain and the pia. In each case results were expressed 
as mean ± SEM. Cell counts of the specific neuronal subpopulations were obtained using the ITCN 
plugin for ImageJ and results were expressed as mean ± SEM. A priori criteria were defined for 
analysis. Statistical analysis was performed using R unpaired Student’s t test assuming equal vari-
ance was used for the pairwise comparisons.
Antibodies and image acquisition
Primary antibodies and dilutions were as follows: anti-ßgal (CGAL-45; 1:500; Immunology Consultants 
Laboratory, Portland OR), anti-SATB2 (ab51502; 1:50; Abcam, Cambridge, UK), anti-CUX1 (sc-13024; 
1:100; Santa Cruz Biotechnology, Dallas, TX), anti-pH3 (06-570; 1:500; Millipore, Billerica, MA), anti-TBR2 
Developmental biology and stem cells | Genes and chromosomes
Sauvageau et al. eLife 2013;2:e01749. DOI: 10.7554/eLife.01749 19 of 24
Research article
(1:2000; Gift from Robert F Hevner Lab), anti-CTIP2 (ab18465; 1:100; Abcam), anti-TLE4 (sc-9125; 
1:100; Santa Cruz), anti-vGLUT2 (MAB5504; 1:50; Millipore), anti-5-HTT (PC177L; 1:1000; Millipore), 
anti-TUJ1 (mms-435P; 1:1000; Covance, Princeton, NJ). Secondary antibodies were from the Molecular 
Probes (Eugene, OR) Alexa series and were used at 1:750 dilution. Immunostained sections were 
imaged using a Nikon 90i fluorescence microscope equipped with a Retiga Exi camera (Q-IMAGING) 
and acquired  with Volocity image analysis software v4.0.1 (Improvision).
Cytochrome oxidase staining
linc–Brn1b−/− and wild-type littermates at P7 were anesthetized, perfused with 4% PFA, decapitated, 
and the brain rapidly removed. The brains were post-fixed in 4% PFA for 3 hr at 4°C. Cortices containing 
the barrel field were dissected and flattened as described (Welker and Woolsey, 1974), post-fixed 
in 4% PFA for 12–14 hr at 4°C and sectioned by using a vibratome (80 μm). Sections were incubated 
in phosphate buffer containing 0.5 mg/ml DAB, 0.18 mg cytochrome C, and 40 mg/ml sucrose for 3–5 hr 
at 37°C, rinsed, and mounted in Fluoromount-G (SouthernBiotech, Birmingham, AL) (Wong-Riley, 1979; 
Land and Simons, 1985).
In situ hybridization
Nonradioactive in situ hybridization was performed on 40 μm vibratome sections mounted on 
superfrost slides (Fisher Scientific, Waltham, MA) as previously described (Berger and Hediger, 
2001; Arlotta et al., 2005). The probe for Svet1 was a gift from M Studer. Probes for RorB (nt 
1573-2087 of NM_146095) and Cux2 (nt 1069-11694 of NM_007804) transcripts were generated 
by PCR from mouse brain cDNA and subcloned in pCRII-TOPO (Life Technologies, Carlsbad, CA). 
Antisense riboprobes were generated by in vitro transcription using SP6 or T7 polymerase (Roche 
Applied Science, Penzberg, Germany) as previously described. Sense probes were used as nega-
tive controls.
Single molecule FISH
Single molecule FISH was performedas described by Raj et al. (2008). Briefly, oligonucleotide probes 
targeting and tiling Peril (48 probes) and linc–Brn1b (20 probes) were conjugated to Quasar 570 
fluorophores and HPLC purified (Biosearch Technologies, Petaluma, CA). A list of the Peril and linc–Brn1b 
probes (sequence, position, and %CG content) is provided in Supplementary file 1E. Dissociated 
E14.5 cortical neurospheres or mouse ES cells were fixed in 2% formaldehyde for 10 min, washed twice 
with PBS, and permeabilized with 70% ethanol. The cells were then seeded onto previously gelati-
nized two-chamber cover glasses. Prior to hybridization, the cells were rehydrated in wash buffer 
containing 10% formamide and 2 × SSC for 5 min. Probes (0.5 ng/μl final concentration) were hybridized 
in 10% dextran sulfate, 10% formamide, and 2 × SSC at 37°C overnight. After hybridization, cells were 
washed twice with wash buffer at 37°C for 30 min (with DAPI added to the second wash for nuclear stain-
ing), and twice with 2 × SSC. After the SSC wash, the cells were equilibrated in anti-fade buffer (2 × SSC, 
0.4% glucose, 10 mM Tris pH 8.0) for 3–5 min. Cells were mounted in 100 μl anti-fade buffer supple-
mented with 1 μl of glucose oxidase (G2133-10KU; Sigma-Aldrich, St. Louis, MO) and 1 μl of catalase 
(C3515-10 MG; Sigma-Aldrich) and immediately imaged with a LSM 700 Inverted Confocal microscope 
(Zeiss, Jena, Germany). 25 Z-stacks were taken per field, using DAPI and laser 639 for excitation.
Human neural stem cell culture and differentiation
H1 human neural stem cells were prepared as described previously (Arnold et al., 2008; Goff et al., 
2009) and grown at 37°C, 5% CO2 on 1:4 diluted Matrigel-coated wells in neural proliferation medium 
(NPM; 50% DMEM/F12 Glutamax, 50% Neurobasal medium, 0.5X N2, 0.5X B27 without vitamin A, 
20 ng/ml FGF [Life Technologies]). For differentiation, cells were plated at a density of 106 cells per well 
in a 6-well plate and allowed to proliferate for one day in the NPM medium. Neural induction was then 
initiated by withdrawal of FGF and addition of BDNF by switching the medium to neural differentiation 
medium (NDM; 100% Neurobasal medium, 1X B27 without vitamin A [Life Technologies], 10 ng/ml 
BDNF [Peprotech, Rocky Hill, NJ].) Differentiating cultures were maintained by refreshing NDM every 
other day until collection. Samples of these cultures were collected at days 0, 1, 2, and 4. Remaining 
cells (those designated for collection at days 5, 11, and 18) were replated at day 4 at a density 106 cells 
per well of a Poly-D-lysine/laminin-coated 6-well plate. Cells were harvested with Accutase (Stem Cell 
Technologies, Vancouver, Canada) and RNA collected as described above.
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Western blot
linc–Brn1b−/− and WT E14.5-derived neurospheres (passage 3) and E15.5 cortices were lysed in RIPA 
buffer (1% NP-40, 1% Na-deoxycholate, 0.2% SDS, 50 mM Tris 7.4, 500 mM NaCl) containing protease 
inhibitor cocktail (Roche Applied Science). Proteins were resolved by SDS-PAGE and electroblotted. 
Blots were probed sequentially for BRN1 (anti-BRN1, sc-6028-R, Santa Cruz) and GAPDH (anti-GAPDH, 
sc-365062-R, Santa Cruz) to control for protein loading. Immunoreactive bands were detected by 
enhanced chemiluminescence (SuperSignal, Thermo Fisher Scientific, Waltham, MA), and visualized 
with a Gel Doc (Biorad).
Accession numbers
All primary RNA-Seq data are available at the Gene Expression Omnibus (GSE49581).
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